Results 261 to 270 of about 42,703 (308)
Some of the next articles are maybe not open access.

Disease-modifying antirheumatic drugs

Current Opinion in Rheumatology, 1997
The case for early intervention with disease-modifying antirheumatic drugs is strengthened by published reports during the past year. These drugs include methotrexate, gold sulfasalazine, and antimalarial agents. The American College of Rheumatology issued guidelines for the management of rheumatoid arthritis and for monitoring the toxicity of ...
Bachmeier, Clarissa   +7 more
openaire   +5 more sources

Hepatotoxicity related to antirheumatic drugs

Nature Reviews Rheumatology, 2011
Antirheumatic agents are among commonly used drugs associated with adverse hepatic reactions. Sulfasalazine and azathioprine are among the most important causes of acute hepatotoxicity. Because such a large number of people take NSAIDs, even the rare occurrence of hepatotoxicity from these agents might contribute substantially to the total burden of ...
openaire   +3 more sources

Antirheumatic drug reactions in the lung

Baillière's Clinical Rheumatology, 1993
Drug-induced lung disease during treatment with antirheumatic drugs should be considered in all patients receiving these agents who develop new pulmonary symptoms. When a potential drug-related reaction is identified, the possible offending agents should be discontinued, appropriate respiratory support initiated, and a thorough investigation for other ...
openaire   +3 more sources

Studies on lysosome stabilization by antirheumatic drugs

European Journal of Pharmacology, 1970
Abstract Differential centrifugation was used to isolate a lysosome containing fraction from rat liver homogenate. The influence of cortisone, hydrocortisone, salicylate and chloroquine on the stability of the lysosomes was tested using different labilization procedures.
A. Jørgensen, John Hyttel
openaire   +3 more sources

Antirheumatic drugs in pregnancy and lactation

2013
Antirheumatic drugs in pregnancy and lactation are increasingly a common clinical dilemma. With the shift towards early, aggressive control of autoimmune diseases and with the advent of newer therapeutic agents, there is a need to understand the effects of these medicines in pregnancy and lactation, on fertility in both men and women, and on the ...
Tarnya Marshall   +3 more
openaire   +1 more source

Antirheumatic drugs in pregnancy and lactation

2016
Antirheumatic drugs in pregnancy and lactation are increasingly a common clinical dilemma. With the shift towards early, aggressive control of autoimmune diseases and with the advent of newer therapeutic agents, there is a need to understand the effects of these medicines in pregnancy and lactation, on fertility in both men and women, and on the ...
Poonam Sharma   +2 more
openaire   +1 more source

Pulmonary complications of antirheumatic drug therapy

Seminars in Arthritis and Rheumatism, 1990
Drug-induced pulmonary disease should be considered in all patients receiving these antirheumatic agents who develop new pulmonary symptoms. When a drug reaction is suspected, the possible offending agents should be discontinued, required respiratory support instituted, and infection or other pulmonary processes excluded.
openaire   +3 more sources

Antirheumatic drug therapy in the elderly

1992
In developed nations about 10 percent of the population are elderly, defined as 65 years or older [1]. Predictions forecast a doubling of this percentage by the year 2030 [2]. At present the elderly use approximately 75 percent of doctors’ time and require 20–40 prescriptions per person annually [3].
Walter F. Kean, W. Watson Buchanan
openaire   +2 more sources

Cancer epigenetics in clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Veronica Davalos, Manel Esteller
exaly  

Antirheumatic drugs and eicosanoid synthesis

Scandinavian Journal of Rheumatology, 1988
H. Isomakp   +5 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy